• 1
    Zvibel I, Kraft A. Extracellular matrix and metastasis. In: ZernMA, ReidLM, eds. Extracellular matrix: its chemistry, biology and pathobiology, vol. 22. New York: Marcel Dekker, 1993. 55980.
  • 2
    Nicolson GL. Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1989;1: 100919.
  • 3
    Doerr R, Zvibel I, Chiuten D, D'Olimpio J, Reid LM. Clonal growth of tumors on tissue-specific biomatrices and correlation with organ-site specificity of metastases. Cancer Res 1989;49: 38492.
  • 4
    Zvibel I, Halay E, Reid LM. Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors. Mol Cell Biol 1991;11: 10816
  • 5
    Zvibel I, Brill S, Halpern Z, Papa M. Hepatocyte extracellular matrix modulates expression of growth factors and growth factor receptors in human colon cancer cells. Exp Cell Res 1998;245: 12331.
  • 6
    Zvibel I, Brill S, Halpern Z, Moskovitz S, Yayon A, Papa M. Soluble and matrix associated heparan sulfate proteoglycans increase expression of erb-B2 and erb-B3 in colon cancer cell lines. Int J Cancer 2001;91: 31621.
  • 7
    Zvibel I, Halpern Z, Papa M. Extracellular matrix modulates the expression of growth factors and growth factor receptors in liver-colonizing colon cell lines. Int J Cancer 1998;77: 295301.
  • 8
    Lyon M, Deakin JA, Gallagher JT. Liver heparan sulfate structure. J Biol Chem 1994;269: 1120815.
  • 9
    Reilly CF, Fritze MS, Rosenberg RD. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor. J Cell Physiol 1997;121: 14957.
  • 10
    Johnson GR, Wong L. Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J Biol Chem 1994;269: 2714954.
  • 11
    Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991;64: 8418.
  • 12
    Aviezer D, Yayon A. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor, but not by EGF. Proc Natl Acad Sci USA 1994;91: 121737.
  • 13
    Shlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103: 21125.
  • 14
    Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT. Interaction of hepatocyte growth factor with heparan sulfate. J Biol Chem 1994;269: 1121623.
  • 15
    Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 1992;267: 1033741.
  • 16
    Jayson GC, Gallagher JT. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells. Br J Cancer 1997;75: 916.
  • 17
    Radinsky R. Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur J Cancer 1995;31A: 10915.
  • 18
    Kapitanovic S, Radosevic S, Kapitanovic M andelinovic S, Ferencic Z, Tavassoli M, Primorac D, Sonicki Z, Spaventi S, Pavelic K, Spaventi R. The expression of p185 (HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 1997;112: 110313.
  • 19
    Saeki T, Salomon DS, Johnson GR, Gullick WJ, Mandai K, Yamagami K, Moriwaki S, Tanada M, Takashima S, Tahara E. Association of epidermal growth factor–related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas. Jpn J Clin Oncol 1995;25: 2409.
  • 20
    Block GD, Locke J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, Howard TA, Michalopoulos GK. Population expansion, clonal growth and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGFα in a chemically defined (HGM) medium. J Cell Biol 1996;132: 113349.
  • 21
    Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 1994;269: 11421.
  • 22
    Lider L, Cahalon L, Gilat D, Hershkoviz R, Siegel D, Margalit R, Shoseyov O, Cohen IR. A disaccharide that inhibits tumor necrosis factor α secretion is formed from the extracellular matrix by the enzyme heparanase. Proc Natl Acad Sci USA 1995;92: 503741.
  • 23
    Chowers J, Lider O, Schor H, Barshack I, Tal R, Ariel A, Bar-Meir S, Cohen IR, Cahalon L. Disaccharides derived from heparin or heparan sulfate regulate IL-8 and IL-1β secretion by intestinal epithelial cells. Gastroeneterology 2000;120: 44959.
  • 24
    Adar R, Yayon A. Mapping of heparin binding site on erb-B3 epidermal growth factor receptor. Biochem Biophys Res Commun 2001;283: 15.
  • 25
    deFazio A, Chiew YE, Sini RL, Janes PW, Sutherland RL. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 2000;87: 48798.
  • 26
    Maurer CA, Friess H, Kretschmann B, Zimmermann A, Stauffer A, Baer HU, Korc M, Buchler MW. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 1998; 29; 7717.
  • 27
    Olayoiye MA, Neve RM, Lane HA, Hynes NE. The erbB signaling network: receptor dimerization in development and cancer. EMBO J 2000;19: 315967.
  • 28
    Harari D, Yarden Y. Molecular mechanisms underlying erb-B2/HER2 action in breast cancer. Oncogene 2000;19: 610214.
  • 29
    Slevin M, Krupinski J, Kumar S, Guffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998;78: 9871003.